Cerata Pharmaceuticals LLP operates three independent cGMP-compliant API manufacturing facilities with combined installed capacity exceeding 100 metric tons.
We produce APIs annually, exporting to over 40 countries and consistently meeting global pharmaceutical needs.
We maintain strict quality standards delivering uniform product quality and reliability across all markets.
Meeting World Health Organization Good Manufacturing Practice standards.
Globally recognized business identification and verification.
Three independent cGMP-compliant manufacturing units with advanced infrastructure and technology for API production.
Comprehensive quality management system ensuring compliance with global regulatory standards.
State-of-the-art R&D facilities dedicated to developing innovative APIs with modern analytical equipment.
Comprehensive hormone and steroid API manufacturing with advanced synthesis techniques.
Peptide API manufacturing using cutting-edge technology for complex molecular structures.
Specialized oncology API manufacturing with advanced synthesis techniques and targeted therapies.
